Charles G Eberhart Selected Research

Biomarkers (Surrogate Marker)

3/2021	Long non-coding RNAs in brain tumors.
1/2020	RNA sequencing of corneas from two keratoconus patient groups identifies potential biomarkers and decreased NRF2-antioxidant responses.
5/2018	Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
1/2017	Melanoma subtypes demonstrate distinct PD-L1 expression profiles.
1/2017	Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
1/2016	Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
3/2014	Cytogenetic prognostication within medulloblastoma subgroups.
12/2008	Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles G Eberhart Research Topics

Disease

136	Neoplasms (Cancer) 03/2024 - 03/2002
66	Medulloblastoma 03/2024 - 08/2002
43	Glioma (Gliomas) 01/2023 - 03/2005
33	Glioblastoma (Glioblastoma Multiforme) 09/2022 - 10/2006
32	Brain Neoplasms (Brain Tumor) 01/2023 - 08/2002
18	Astrocytoma (Pilocytic Astrocytoma) 01/2023 - 07/2004
9	Carcinogenesis 01/2016 - 09/2002
8	Rhabdoid Tumor (Rhabdoid Tumors) 06/2022 - 02/2005
8	Hypoxia (Hypoxemia) 04/2022 - 09/2010
8	Carcinoma (Carcinomatosis) 08/2021 - 06/2006
7	Uveal melanoma 06/2022 - 02/2012
6	Neoplasm Metastasis (Metastasis) 09/2022 - 03/2013
6	Retinoblastoma (Glioblastoma, Retinal) 06/2022 - 10/2016
5	Meningioma (Meningiomas) 03/2024 - 10/2005
5	Infections 11/2023 - 02/2005
5	Keratoconus 02/2023 - 05/2011
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 10/2007
4	Diffuse Intrinsic Pontine Glioma 01/2024 - 06/2014
4	Hemorrhage 12/2023 - 11/2002
4	Cysts 12/2022 - 01/2013
4	Retinal Detachment (Retinal Detachments) 12/2022 - 09/2012
4	Melanoma (Melanoma, Malignant) 01/2022 - 08/2014
4	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 06/2003
4	Fuchs' Endothelial Dystrophy 01/2014 - 02/2010
4	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 09/2002
3	Inflammation (Inflammations) 12/2022 - 11/2015
3	Carcinoma in Situ 06/2022 - 12/2019
3	Disease Progression 01/2018 - 01/2014
2	Macular Degeneration (Age-Related Maculopathy) 12/2023 - 01/2014
2	Arteritis 01/2023 - 01/2021
2	Papilloma (Papillomatosis) 06/2022 - 12/2021

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2003
20	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2005
20	Messenger RNA (mRNA)IBA 01/2021 - 06/2003
12	Formaldehyde (Formol)FDA Link 06/2022 - 02/2011
12	ParaffinIBA 06/2022 - 08/2010
11	RNA (Ribonucleic Acid)IBA 10/2023 - 05/2011
11	LigandsIBA 01/2019 - 03/2005
10	Retinaldehyde (Retinal)IBA 12/2023 - 07/2011
10	MicroRNAs (MicroRNA)IBA 05/2019 - 04/2011
10	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2008
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2022 - 09/2008
9	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2016 - 08/2006
8	AmidesIBA 01/2023 - 11/2013
8	Protons (Proton)IBA 01/2023 - 11/2013
8	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 12/2013
8	Biomarkers (Surrogate Marker)IBA 03/2021 - 12/2008
7	Histones (Histone)IBA 01/2024 - 04/2009
7	Small Interfering RNA (siRNA)IBA 06/2022 - 03/2005
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 09/2010
7	Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2012
7	Phosphotransferases (Kinase)IBA 01/2021 - 09/2008
6	Temozolomide (Temodar)FDA LinkGeneric 09/2022 - 02/2013
6	Oxygen (Dioxygen)IBA 01/2017 - 09/2010
5	dipinacoline glutamateIBA 01/2024 - 09/2013
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 10/2013
5	TOR Serine-Threonine KinasesIBA 01/2021 - 04/2005
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 06/2003
4	NucleotidesIBA 03/2022 - 10/2019
4	Glutamine (L-Glutamine)FDA Link 03/2022 - 10/2019
4	CytokinesIBA 10/2021 - 09/2013
4	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 06/2006
4	CateninsIBA 01/2019 - 12/2012
4	ChromatinIBA 01/2018 - 12/2010
4	AntigensIBA 01/2017 - 10/2003
4	MRK 003IBA 11/2016 - 02/2012
4	Digoxin (Digitek)FDA LinkGeneric 11/2015 - 09/2010
4	EnzymesIBA 11/2013 - 10/2007
4	PolymersIBA 02/2013 - 11/2002
4	cyclopamineIBA 12/2010 - 08/2002
3	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 10/2017
3	Hypoxia-Inducible Factor 1IBA 12/2023 - 02/2016
3	SteroidsIBA 12/2022 - 09/2012
3	Glutathione (Reduced Glutathione)IBA 03/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2017
3	trametinibIBA 01/2021 - 01/2018
3	Coloring Agents (Dyes)IBA 11/2017 - 08/2006
3	OligonucleotidesIBA 01/2016 - 07/2007
3	Lysine (L-Lysine)FDA Link 06/2014 - 04/2009
3	Notch ReceptorsIBA 02/2012 - 11/2004
3	beta CateninIBA 05/2004 - 09/2002
2	PlatinumIBA 03/2024 - 01/2021
2	Decitabine FDA Link 01/2024 - 08/2014
2	Untranslated RNA (Noncoding RNA)IBA 10/2023 - 01/2021
2	Capsules (Microcapsules)IBA 12/2022 - 03/2021
2	Fluorescein (Funduscein)FDA LinkGeneric 10/2022 - 01/2021
2	LipidsIBA 04/2022 - 01/2022
2	Glutamic Acid (Glutamate)FDA Link 03/2022 - 03/2016
2	sapanisertibIBA 01/2022 - 03/2016
2	Long Noncoding RNAIBA 01/2022 - 12/2021
2	Keratins (Keratin)IBA 12/2021 - 01/2013
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2017
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2019

Therapy/Procedure

47	Therapeutics 12/2023 - 07/2003
15	Drug Therapy (Chemotherapy) 03/2024 - 07/2004
9	Radiotherapy 01/2023 - 07/2004
4	Immunotherapy 12/2021 - 10/2003
2	Craniospinal Irradiation 03/2024 - 01/2023
2	Craniotomy 03/2024 - 03/2002